Project Grant R01MH137211

Award Date 5/1/25
Completion Date 3/31/30
Dollars Obligated $808K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants provides $638,872 to The Feinstein Institutes for Medical Research to elucidate the mechanisms by which deep brain stimulation (DBS) of the medial forebrain bundle modulates the reward network in individuals with treatment-resistant depression. The project aims to characterize the temporality of reward network changes induced by DBS using functional and...
This $2,809,928 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports a multi-site, double-blind, randomized controlled trial to evaluate the efficacy of a transdiagnostic intervention for sleep and circadian dysfunction (TRANS-C) in improving depression symptoms and reducing suicide risk in older adults. The primary goal is to confirm TRANS-C's target engagement (sleep-wake rhythm stability) and its...
The National Institute of Mental Health (NIMH) awarded Emory University a $156,500 Project Grant under the Mental Health Research Grants (CFDA 93.242) program. The grant, titled "Identifying First-Line Treatment Failure for Earlier Referral to Alternative Treatments in Depression," aims to develop a framework for stratifying patients with major depressive disorder who are likely to experience true treatment failure, rather than partial response, to first-line therapies such as SSRIs,...
This $107,948 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to leverage ultra-high field magnetic resonance imaging (MRI) to investigate how repetitive transcranial magnetic stimulation (rTMS) alters glutamate signaling and functional connectivity in the salience network of patients with major depressive disorder. The award supports a research project being conducted by The Trustees of the...
This $194,157 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support the development and piloting of a novel intervention to treat post-COVID-19 cognitive impairment (CI) and depression in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). The project aims to integrate two evidence-based interventions - cognitive rehabilitation based on goal management training and cognitive...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under their Mental Health Research Grants program (CFDA 93.242), provides $784,096 to The Leland Stanford Junior University (Stanford University) to conduct research aimed at improving depression treatment by establishing reliable markers of prefrontal cortex excitability. The project aims to investigate how adjusting transcranial magnetic stimulation (TMS) parameters affects neural activity, optimize a...
This federal Project Grant award in the amount of $2,262,455.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a longitudinal study examining the developmental pathways and adult outcomes of two distinct subtypes of depression: time-limited depression (TLD) and chronic-intermittent depression (CID). The study, conducted by the Research Foundation for the State University of New York (Stony Brook University), aims...
This federal Cooperative Agreement award of $1,377,361 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to develop and validate a new approach for predicting optimal treatment outcomes in patients with treatment-resistant depression (TRD). The two-phase project will leverage machine learning and neuroimaging biomarkers to optimize the selection of either accelerated repetitive transcranial magnetic stimulation (rTMS) or...
The National Institute of Mental Health (NIMH) awarded a $100,748 Project Grant under CFDA 93.242 - Mental Health Research Grants to the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate the neurocomputational mechanisms underlying the influence of social interaction on mood. The central hypothesis is that norm prediction errors, similar to reward prediction errors, influence both short-term and long-term changes in mood, and are encoded by single-unit neurons in the human...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to characterize the role of sleep brain dynamics in the emergence of depression among adolescents. The $195,000 award was granted to the Research Institute at Nationwide Children's Hospital, a prominent non-profit research organization in Ohio. The key objectives of this 2-year research project are to: 1) identify the space-time profiles...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $808,417 to Stony Brook University to conduct a clinical trial evaluating the role of the metabotropic glutamate receptor subtype 5 (mGluR5) in the antidepressant mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I). The 5-year project, starting on May 1, 2025, will assess whether CBT-I reduces mGluR5 density, and if this reduction correlates with improved sleep latency and depression outcomes in 42 adults with major depressive disorder. The research aims to establish mGluR5 as a potential personalized marker of CBT-I treatment efficacy, as well as explore the therapeutic implications of using a lifestyle-based intervention to alter mGluR5 density, which could have broader applications beyond depression.

Generated 5/13/25, 2:54 AM